BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26443437)

  • 1. Individual Vaccination as Nash Equilibrium in a SIR Model with Application to the 2009-2010 Influenza A (H1N1) Epidemic in France.
    Laguzet L; Turinici G
    Bull Math Biol; 2015 Oct; 77(10):1955-84. PubMed ID: 26443437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal individual strategies for influenza vaccines with imperfect efficacy and durability of protection.
    Salvarani F; Turinici G
    Math Biosci Eng; 2018 Jun; 15(3):629-652. PubMed ID: 30380323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of information on intentions to vaccinate in a potential epidemic: Swine-origin Influenza A (H1N1).
    Chanel O; Luchini S; Massoni S; Vergnaud JC
    Soc Sci Med; 2011 Jan; 72(2):142-8. PubMed ID: 21163566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The coexistence or replacement of two subtypes of influenza.
    Asaduzzaman SM; Ma J; van den Driessche P
    Math Biosci; 2015 Dec; 270(Pt A):1-9. PubMed ID: 26453807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: results of a national vaccination campaign.
    Bone A; Guthmann JP; Nicolau J; Lévy-Bruhl D
    Vaccine; 2010 Nov; 28(51):8157-61. PubMed ID: 20937310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza in Poland in 2011-2012 and in 2011/2012 and 2012/2013 epidemic seasons.
    Czarkowski MP; Hallmann-Szelińska E; Staszewska E; Bednarska K; Kondratiuk K; Brydak LB
    Przegl Epidemiol; 2014; 68(3):455-63, 559-65. PubMed ID: 25391010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An epidemic model with a multistage vaccine.
    DeLegge A; Hunzinger K; Khatri R; Munir K
    Bull Math Biol; 2015 Mar; 77(3):499-513. PubMed ID: 25698086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Wait and see" vaccinating behaviour during a pandemic: a game theoretic analysis.
    Bhattacharyya S; Bauch CT
    Vaccine; 2011 Jul; 29(33):5519-25. PubMed ID: 21601606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pandemic H1N1 influenza: predicting the course of a pandemic and assessing the efficacy of the planned vaccination programme in the United States.
    Towers S; Feng Z
    Euro Surveill; 2009 Oct; 14(41):19358. PubMed ID: 19883540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seasonal influenza vaccination coverage in France during two influenza seasons (2007 and 2008) and during a context of pandemic influenza A(H1N1) in 2009.
    Tuppin P; Samson S; Weill A; Ricordeau P; Allemand H
    Vaccine; 2011 Jun; 29(28):4632-7. PubMed ID: 21550376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with 2009 monovalent H1N1 vaccine coverage: a cross sectional study of 1,308 patients with psoriasis in France.
    Sbidian E; Tubach F; Pasquet B; Paul C; Jullien D; Sid-Mohand D; Bachelez H;
    Vaccine; 2012 Aug; 30(39):5703-7. PubMed ID: 22828586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France.
    Dauvilliers Y; Arnulf I; Lecendreux M; Monaca Charley C; Franco P; Drouot X; d'Ortho MP; Launois S; Lignot S; Bourgin P; Nogues B; Rey M; Bayard S; Scholz S; Lavault S; Tubert-Bitter P; Saussier C; Pariente A;
    Brain; 2013 Aug; 136(Pt 8):2486-96. PubMed ID: 23884811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prioritization of vaccine strategy using an age-dependent mathematical model for 2009 A/H1N1 influenza in the Republic of Korea.
    Kim S; Jung E
    J Theor Biol; 2019 Oct; 479():97-105. PubMed ID: 31330133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal control of vaccination dynamics during an influenza epidemic.
    Jaberi-Douraki M; Moghadas SM
    Math Biosci Eng; 2014 Oct; 11(5):1045-63. PubMed ID: 25347806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematical model of transmission dynamics and optimal control strategies for 2009 A/H1N1 influenza in the Republic of Korea.
    Kim S; Lee J; Jung E
    J Theor Biol; 2017 Jan; 412():74-85. PubMed ID: 27769686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination of an adolescent group with A (H3N2) + A(HSW1N1) bivaccine before an A (H1N1) influenza epidemic.
    Stumpa A; Cihla F; Tůmová B; Husek V; Slezácek J
    Acta Virol; 1979 Sep; 23(5):443-5. PubMed ID: 42307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Model to estimate epidemic patterns of influenza A (H1N1) in Mexico].
    Navarro-Robles E; Martínez-Matsushita L; López-Molina R; Fritz-Hernández J; Flores-Aldana BA; Mendoza-Pérez JC
    Rev Panam Salud Publica; 2012 Apr; 31(4):269-74. PubMed ID: 22652965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of the vaccination campaign against A(H1N1) influenza in pregnant women in France: results from a national survey.
    Blondel B; Mahjoub N; Drewniak N; Launay O; Goffinet F
    Vaccine; 2012 Aug; 30(38):5661-5. PubMed ID: 22781306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early estimates of 2014/15 seasonal influenza vaccine effectiveness in preventing influenza-like illness in general practice using the screening method in France.
    Souty C; Blanchon T; Bonmarin I; Lévy-Bruhl D; Behillil S; Enouf V; Valette M; Bouscambert M; Turbelin C; Capai L; Roussel V; Hanslik T; Falchi A
    Hum Vaccin Immunother; 2015; 11(7):1621-5. PubMed ID: 26061896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Universal influenza vaccination and live attenuated influenza vaccination of children.
    Glezen WP
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S104-9. PubMed ID: 18820568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.